key: cord-0783325-j26nyrz2
authors: Merino, Anna; Laguna, Javier; Molina, Angel; Vlagea, Alexandru; Sibila, Oriol
title: SARS‐CoV‐2 pneumonia and atypical lymphocyte morphology in pleural fluid
date: 2021-06-19
journal: Int J Lab Hematol
DOI: 10.1111/ijlh.13630
sha: 89c4513f87439f3f7e9c4fdefcc9902570eabce4
doc_id: 783325
cord_uid: j26nyrz2

nan

Dear Editors, Atypical or reactive lymphocytes circulating in peripheral blood of some patients with COVID-19 infection (hereinafter named COVID-19 RL) have been reported in previous publications. [1] [2] [3] [4] [5] [6] In a recent publication, these lymphocytes were correlated with the evolution and prognosis of the disease. 2 In this letter, we present the case of a patient with COVID-19 infection in which a pneumonia complicated with parapneumonic effusion was also demonstrated.

Morphological characteristics of the COVID-19 RL found in the pleural fluid are described.

A 76 year-old woman with diabetes mellitus and stage IV breast carcinoma (diagnosed in 2012) was admitted to the Emergency Department of the Hospital for asthenia, vomiting and fever (37.5ºC) in the last two weeks. White blood cell (WBC), red blood cell and platelet counts were normal. Differential WBC count showed high values of neutrophils (9.2 × 10 9 /L) and low values of lymphocytes (0.5 × 10 9 /L). Peripheral blood smear review showed low percentages of normal lymphocytes (5%). Biochemical blood tests showed high values of C-reactive protein (137 mg/L; normal <10), ferritin (2.06 nmol/L, nor-mal<0.44), lactate dehydrogenase (352 U/L, normal <234) and D-dimer (3,200 ng/mL; normal <500) were found (see Table 1 ).

Positive RT-PCR and chest X-ray examination confirmed the di- Literature review reveals that prevalence of pleural effusion can be as high as 14% related to SARS-CoV-2 pneumonia. [8] [9] [10] [11] [12] In a previous work, the incidence of pleural effusion in patients with acute viral infection increased from 8% incidence to 18% when pleural ultrasonography was used as a screening tool. 13 

Authors declare no conflict of interest.

Anna Merino: designed the study and wrote the manuscript.

Javier Laguna and Angel Molina: collected and analysed the data.

Alexandru Vlagea: performed the immunophenotypic study. Oriol

Sibila: performed the clinical evaluation and patient management.

Data available on request from the authors. 

Atypical lymphocytes in peripheral blood of patients with COVID-19

Atypical lymphoid cells circulating in blood in COVID-19 infection: morphology, immunophenotype and prognosis value

COVID-19 and the clinical laboratory

SARS-CoV-2: A new aetiology for atypical lymphocytes

Morphological anomalies of circulating blood cells in COVID-19 infection

Morphological changes in a case of SARS-CoV-2 infection

Epstein-barr virus-positive pleural effusion. clinical features, cytomorphologic characteristics and flow cytometric immunophenotyping

Comparison of chest CT findings between COVID-19 pneumonia and other types of viral pneumonia: a twocenter retrospective study

CT manifestations of coronavirus disease-2019: a retrospective analysis of 73 cases by disease severity

The clinical and chest CT features associated with severe and critical COVID-19 pneumonia

Positive pleural fluid RT-PCR for virus detection in SARS-CoV-2 pneumonia

First detection of SARS-CoV-2 by real-time reverse transcriptase-polymerase chain reaction assay in pleural fluid

Resolution of pleural effusion